Conquering Diseases

Study Of An Investigational Drug Combination Following Surgery For Newly Diagnosed High-Risk Endometrial Cancer

Description

Seeking women with newly diagnosed high-risk endometrial cancer that will be treated with surgery to remove the cancer for a study of an investigational drug given in combination with chemotherapy.

Overview

Participants in this study will be randomly assigned to get either the investigational drug or a placebo (looks like the drug but contains no medicine). All participants will get the chemotherapy.

What we're hoping for

We are studying whether adding an investigational drug to chemotherapy following surgery to completely remove high-risk endometrial cancer improves control of cancer growth.

Additional Information

ClinicalTrials.gov Identifier: NCT04634877

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMHC Memorial Campus

281 Lincoln St. 

Worcester,MA 01605

508-334-1000